Group items tagged

Launch of new products is expected to propel growth of the metabolomics market. For instance, in January 2021, JUNO Metabolomics launched the JUNO Viral Surveillance Platform based on its proprietary AI-Based Informatics System. Similarly, in June 2019, Bruker Corp. presented mass spectrometry and Nuclear Magnetic Resonance systems and other solutions for molecular phenomics and clinical metabolomics research at Metabolomics 2019. Moreover, increasing prevalence of chronic disorders is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Integration of Artificial Intelligence (AI) with metabolomics is expected to offer lucrative growth opportunities for players in the metabolomics market. For instance, in July 2020, ReviveMed, an AI-driven drug discovery platform, collaborated with Bristol Myers Squibb for an AI-driven metabolomics study that will leverage ReviveMed's AI platform to better understand mechanisms of response and resistance to immunotherapies in patients with cancer. Moreover, increasing demand for metabolomics is also expected to aid in growth of the market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/integration-of-ai-with-metabolomics-and.html

In this issue of "The 10 Most Innovative Companies Bringing AI to Healthcare", we have highlighted some of the renowned organizations from all over the globe, which have attained the feat of integrating AI into their solutions successfully and are now ready to play the next big inning.

Instapay Healthcare Services is a good example of how AI can be used to check medical credentials. Their platform offers advanced verification and validation, faster processing of applications, and updates and alerts in real time. These features make it easier for healthcare organisations and providers to sign up providers and improve the overall experience for both groups.

The UK government has pledged £133m to healthcare innovation funding, which will help boost the country's innovations in medical imaging and artificial intelligence (AI), among other areas.

To help manage diabetes, an artificial pancreas system, which is capable of blood sugar levels to introduce an appropriate amount of insulin into the blood.

Cancer Research UK has announced a £56m research network to transform the UK into a global hub for radiotherapy study. By leveraging the use of the latest techniques, such as FLASH radiotherapy and artificial intelligence (AI), the network aims to accelerate the development of advanced radiotherapy.

Brain tumors in a particular part of the brain, known as the posterior fossa, are the largest cause of death from cancer in children.

UK-based online therapy provider Ieso Digital Health has applied deep learning to provide new insights into which aspects of psychotherapy are the most effective.